Some observations on complement-fixing antibodies to the EB virus

Complement-fixing antibodies against an antigen prepared from the EB3 line of cultured Burkitt tumour cells were studied in various groups of patients and control individuals. Higher antibody titres were observed in patients with Burkitt's tumour than in African patients with other diagnoses. S...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical pathology 1971-12, Vol.24 (9), p.801-804
Main Authors: Sutton, R. N. P., Marston, S. D., Emond, R. T. D.
Format: Article
Language:English
Subjects:
Antibodies - analysis
Antigens
Antigens, Viral
Burkitt Lymphoma - immunology
Cell Line
Complement Fixation Tests
Culture Techniques
Fluorescent Antibody Technique
Herpesviridae - immunology
Herpesvirus 4, Human - immunology
Humans
Infectious Mononucleosis - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b476t-5c85b899b9d081d1cf21c9f2597cd9f26ba2107e97fe5e3e4d514c937e0e01953
cites cdi_FETCH-LOGICAL-b476t-5c85b899b9d081d1cf21c9f2597cd9f26ba2107e97fe5e3e4d514c937e0e01953
container_end_page 804
container_issue 9
container_start_page 801
container_title Journal of clinical pathology
container_volume 24
creator Sutton, R. N. P.
Marston, S. D.
Emond, R. T. D.
description Complement-fixing antibodies against an antigen prepared from the EB3 line of cultured Burkitt tumour cells were studied in various groups of patients and control individuals. Higher antibody titres were observed in patients with Burkitt's tumour than in African patients with other diagnoses. Significantly more medical students and nurses with a history of infectious mononucleosis possessed antibodies than those with no such history. Low levels of antibody were observed in patients during the acute phase of infectious mononucleosis and these levels were significantly lower than those in patients admitted to the same hospital with other diagnoses. During the early months following the acute phase of illness, EB complement-fixing antibodies remained stationary or apparently declined in titre but, in patients tested one or more years later, significantly higher antibody levels were observed.
doi_str_mv 10.1136/jcp.24.9.801
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_477186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3970956291</sourcerecordid><originalsourceid>FETCH-LOGICAL-b476t-5c85b899b9d081d1cf21c9f2597cd9f26ba2107e97fe5e3e4d514c937e0e01953</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EKkvhxhUpEhJcyOKJHTs-9FBW3RZpASGg4mY5zqT1ksSLnazKv8erXa1aDpzm8L4380aPkJdA5wBMvF_bzbzgczWvKDwiM-CyyDlw8ZjMKC0gV5KLp-RZjGtKgUlgJ-SEM8ZLLmbk_JvvMfN1xLA1o_NDzPyQWd9vOuxxGPPW3bnhJjPD6GrfOIzZ6LPxFrOLD9nWhSk-J09a00V8cZin5Mfy4vviKl99ufy4OF_lNZdizEtblXWlVK0aWkEDti3AqrYolbRNmqI2BVCJSrZYIkPelMCtYhIpUlAlOyVn-72bqe6xsSlcMJ3eBNeb8Ed74_RDZXC3-sZvNZcSKpH8bw7-4H9PGEfdu2ix68yAfoq6gkLwiu3A1_-Aaz-FIf2mQUrKVKnYLs67PWWDjzFge0wCVO960akXXXCtdOol4a_upz_ChyKSnu91F0e8O8om_NJCMlnqz9cLvZLX8HX56adeJv7tnq_79f8v_wVgj6T7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770395935</pqid></control><display><type>article</type><title>Some observations on complement-fixing antibodies to the EB virus</title><source>PubMed Central</source><creator>Sutton, R. N. P. ; Marston, S. D. ; Emond, R. T. D.</creator><creatorcontrib>Sutton, R. N. P. ; Marston, S. D. ; Emond, R. T. D.</creatorcontrib><description>Complement-fixing antibodies against an antigen prepared from the EB3 line of cultured Burkitt tumour cells were studied in various groups of patients and control individuals. Higher antibody titres were observed in patients with Burkitt's tumour than in African patients with other diagnoses. Significantly more medical students and nurses with a history of infectious mononucleosis possessed antibodies than those with no such history. Low levels of antibody were observed in patients during the acute phase of infectious mononucleosis and these levels were significantly lower than those in patients admitted to the same hospital with other diagnoses. During the early months following the acute phase of illness, EB complement-fixing antibodies remained stationary or apparently declined in titre but, in patients tested one or more years later, significantly higher antibody levels were observed.</description><identifier>ISSN: 0021-9746</identifier><identifier>EISSN: 1472-4146</identifier><identifier>DOI: 10.1136/jcp.24.9.801</identifier><identifier>PMID: 4334546</identifier><identifier>CODEN: JCPAAK</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>Antibodies - analysis ; Antigens ; Antigens, Viral ; Burkitt Lymphoma - immunology ; Cell Line ; Complement Fixation Tests ; Culture Techniques ; Fluorescent Antibody Technique ; Herpesviridae - immunology ; Herpesvirus 4, Human - immunology ; Humans ; Infectious Mononucleosis - immunology</subject><ispartof>Journal of clinical pathology, 1971-12, Vol.24 (9), p.801-804</ispartof><rights>Copyright BMJ Publishing Group LTD Dec 1971</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b476t-5c85b899b9d081d1cf21c9f2597cd9f26ba2107e97fe5e3e4d514c937e0e01953</citedby><cites>FETCH-LOGICAL-b476t-5c85b899b9d081d1cf21c9f2597cd9f26ba2107e97fe5e3e4d514c937e0e01953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC477186/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC477186/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4334546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sutton, R. N. P.</creatorcontrib><creatorcontrib>Marston, S. D.</creatorcontrib><creatorcontrib>Emond, R. T. D.</creatorcontrib><title>Some observations on complement-fixing antibodies to the EB virus</title><title>Journal of clinical pathology</title><addtitle>J Clin Pathol</addtitle><description>Complement-fixing antibodies against an antigen prepared from the EB3 line of cultured Burkitt tumour cells were studied in various groups of patients and control individuals. Higher antibody titres were observed in patients with Burkitt's tumour than in African patients with other diagnoses. Significantly more medical students and nurses with a history of infectious mononucleosis possessed antibodies than those with no such history. Low levels of antibody were observed in patients during the acute phase of infectious mononucleosis and these levels were significantly lower than those in patients admitted to the same hospital with other diagnoses. During the early months following the acute phase of illness, EB complement-fixing antibodies remained stationary or apparently declined in titre but, in patients tested one or more years later, significantly higher antibody levels were observed.</description><subject>Antibodies - analysis</subject><subject>Antigens</subject><subject>Antigens, Viral</subject><subject>Burkitt Lymphoma - immunology</subject><subject>Cell Line</subject><subject>Complement Fixation Tests</subject><subject>Culture Techniques</subject><subject>Fluorescent Antibody Technique</subject><subject>Herpesviridae - immunology</subject><subject>Herpesvirus 4, Human - immunology</subject><subject>Humans</subject><subject>Infectious Mononucleosis - immunology</subject><issn>0021-9746</issn><issn>1472-4146</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1971</creationdate><recordtype>article</recordtype><recordid>eNp9kUFv1DAQhS0EKkvhxhUpEhJcyOKJHTs-9FBW3RZpASGg4mY5zqT1ksSLnazKv8erXa1aDpzm8L4380aPkJdA5wBMvF_bzbzgczWvKDwiM-CyyDlw8ZjMKC0gV5KLp-RZjGtKgUlgJ-SEM8ZLLmbk_JvvMfN1xLA1o_NDzPyQWd9vOuxxGPPW3bnhJjPD6GrfOIzZ6LPxFrOLD9nWhSk-J09a00V8cZin5Mfy4vviKl99ufy4OF_lNZdizEtblXWlVK0aWkEDti3AqrYolbRNmqI2BVCJSrZYIkPelMCtYhIpUlAlOyVn-72bqe6xsSlcMJ3eBNeb8Ed74_RDZXC3-sZvNZcSKpH8bw7-4H9PGEfdu2ix68yAfoq6gkLwiu3A1_-Aaz-FIf2mQUrKVKnYLs67PWWDjzFge0wCVO960akXXXCtdOol4a_upz_ChyKSnu91F0e8O8om_NJCMlnqz9cLvZLX8HX56adeJv7tnq_79f8v_wVgj6T7</recordid><startdate>19711201</startdate><enddate>19711201</enddate><creator>Sutton, R. N. P.</creator><creator>Marston, S. D.</creator><creator>Emond, R. T. D.</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19711201</creationdate><title>Some observations on complement-fixing antibodies to the EB virus</title><author>Sutton, R. N. P. ; Marston, S. D. ; Emond, R. T. D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b476t-5c85b899b9d081d1cf21c9f2597cd9f26ba2107e97fe5e3e4d514c937e0e01953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1971</creationdate><topic>Antibodies - analysis</topic><topic>Antigens</topic><topic>Antigens, Viral</topic><topic>Burkitt Lymphoma - immunology</topic><topic>Cell Line</topic><topic>Complement Fixation Tests</topic><topic>Culture Techniques</topic><topic>Fluorescent Antibody Technique</topic><topic>Herpesviridae - immunology</topic><topic>Herpesvirus 4, Human - immunology</topic><topic>Humans</topic><topic>Infectious Mononucleosis - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sutton, R. N. P.</creatorcontrib><creatorcontrib>Marston, S. D.</creatorcontrib><creatorcontrib>Emond, R. T. D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sutton, R. N. P.</au><au>Marston, S. D.</au><au>Emond, R. T. D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Some observations on complement-fixing antibodies to the EB virus</atitle><jtitle>Journal of clinical pathology</jtitle><addtitle>J Clin Pathol</addtitle><date>1971-12-01</date><risdate>1971</risdate><volume>24</volume><issue>9</issue><spage>801</spage><epage>804</epage><pages>801-804</pages><issn>0021-9746</issn><eissn>1472-4146</eissn><coden>JCPAAK</coden><abstract>Complement-fixing antibodies against an antigen prepared from the EB3 line of cultured Burkitt tumour cells were studied in various groups of patients and control individuals. Higher antibody titres were observed in patients with Burkitt's tumour than in African patients with other diagnoses. Significantly more medical students and nurses with a history of infectious mononucleosis possessed antibodies than those with no such history. Low levels of antibody were observed in patients during the acute phase of infectious mononucleosis and these levels were significantly lower than those in patients admitted to the same hospital with other diagnoses. During the early months following the acute phase of illness, EB complement-fixing antibodies remained stationary or apparently declined in titre but, in patients tested one or more years later, significantly higher antibody levels were observed.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>4334546</pmid><doi>10.1136/jcp.24.9.801</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9746
ispartof Journal of clinical pathology, 1971-12, Vol.24 (9), p.801-804
issn 0021-9746
1472-4146
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_477186
source PubMed Central
subjects Antibodies - analysis
Antigens
Antigens, Viral
Burkitt Lymphoma - immunology
Cell Line
Complement Fixation Tests
Culture Techniques
Fluorescent Antibody Technique
Herpesviridae - immunology
Herpesvirus 4, Human - immunology
Humans
Infectious Mononucleosis - immunology
title Some observations on complement-fixing antibodies to the EB virus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A49%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Some%20observations%20on%20complement-fixing%20antibodies%20to%20the%20EB%20virus&rft.jtitle=Journal%20of%20clinical%20pathology&rft.au=Sutton,%20R.%20N.%20P.&rft.date=1971-12-01&rft.volume=24&rft.issue=9&rft.spage=801&rft.epage=804&rft.pages=801-804&rft.issn=0021-9746&rft.eissn=1472-4146&rft.coden=JCPAAK&rft_id=info:doi/10.1136/jcp.24.9.801&rft_dat=%3Cproquest_pubme%3E3970956291%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b476t-5c85b899b9d081d1cf21c9f2597cd9f26ba2107e97fe5e3e4d514c937e0e01953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1770395935&rft_id=info:pmid/4334546&rfr_iscdi=true